Page 169 - ESHRE2019
P. 169

 11:00 O-267
Mitotic arrest deficient 1 like 1 (MAD1L1) and MAD2L1 gene variations in products of conception with aneuploidy
N. Hosseini1,2, M. Bazrgar3, A. Amiri-Yekta3, R. Kariminejad4, A. Kariminejad4, H. Najmabadi5
1Department of Genetics- Reproductive Biomedicine Research Center- Royan Institute for Reproductive Biomedicine- ACECR- Tehran- Iran, Genetics, Tehran, Iran
2Department of Molecular Genetics- Faculty of Basic Sciences and Advanced Technologies in biology- University of Science and Culture- ACECR- Tehran- Iran., Molecular Genetics, Tehran, Iran
3Department of Genetics- Reproductive Biomedicine Research Center- Royan Institute for Reproductive Biomedicine- ACECR- Tehran- Iran., Genetics, Tehran, Iran
4Kariminejad-Najmabadi Pathology & Genetics Center- Tehran- Iran., Cytogenetics, Tehran, Iran 5Kariminejad-Najmabadi Pathology & Genetics Center- Tehran- Iran., molecular Genetics, Tehran, Iran
Molecular analysis of Products of Conception (POC) provides comprehensive understanding of the chromosomal causes of clinical miscarriage
N. Al-Asmar1, C. Cinnioglu2, A. Akinwole3, L. Rodrigo1, I. Campos-Galindo1, M. Riboldi4, M.E. Poo5, R. Chopra6, R. Khajuria7, C. Simon8, C. Rubio1
1Igenomix Spain, Genetics, Paterna, Spain
2Igenomix USA, Genetics, Los Angeles, U.S.A.
3Igenomix USA, Genetics, Miami, U.S.A.
4Igenomix Brasil, Genetics, Sao Paulo, Brazil
5Igenomix Mexico, Genetics, Mexico City, Mexico 6Igenomix Dubai, Genetics, Dubai, United Arab Emirates 7Igenomix India, Genetics, New Delhi, India
8Igenomix Foundation, Medical, Valencia, Spain
The implications of unsuccessful IVF/ICSI cycles for future placental development
C. Sacha1, K. James2, A. Harris1, J. Yeh1, I. Souter1, D. Roberts
1Massachusetts General Hospital and Harvard Medical School, Division of Reproductive Endocrinology and Infertility, Boston, U.S.A.
2Massachusetts General Hospital and Harvard Medical School, Deborah Kelly Center for Outcomes Research- Department of OB/GYN, Boston, U.S.A.
3Massachusetts General Hospital and Harvard Medical School, Department of Pathology, Boston, U.S.A.
   11:15 O-268
    11:30 O-269
   SCIENTIFIC PROGRAMME, WEDNESDAY, 26 JUNE I VIENNA, AUSTRIA – 23 TO 26 JUNE 2019 169
   SCIENTIFIC PROGRAMME WEDNESDAY, 26 JUNE











































































   167   168   169   170   171